GH Q4 2025 Earnings — Guardant Health, Inc. Revenue & Financial Results | Market Cap Arena

GHGuardant Health, Inc.

$12B

Q4 2025 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$281M+39.4% YoY

Gross Profit

$182M64.6% margin

Operating Income

-$121M-43.0% margin

Net Income

-$128M-45.7% margin

EPS (Diluted)

$-1.00

QoQ Revenue Growth

+6.1%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$42M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$2.0B

Total Liabilities

$2.1B

Stockholders' Equity

-$99M

Cash & Equivalents

$378M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$281M	$202M	+39.4%
Gross Profit	$182M	$124M	+46.3%
Operating Income	-$121M	-$126M	+4.1%
Net Income	-$128M	-$111M	-15.8%

Revenue Segments

Oncology

$190M68%

Biopharma & Data

$54M19%

Screening

$35M12%

Licensing & Other

$2M1%

Geographic Segments

UNITED STATES

$264M94%

Non-US

$18M6%